Galectin Therapeutics Inc (GALT)
0.8901
-0.14
(-13.58%)
USD |
NASDAQ |
Dec 23, 16:00
0.90
+0.01
(+1.11%)
After-Hours: 20:00
Galectin Therapeutics Enterprise Value: 144.36M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Alaunos Therapeutics Inc | 1.566M |
| SELLAS Life Sciences Group Inc | 42.36M |
| Oragenics Inc | 3.306M |
| Anavex Life Sciences Corp | 593.03M |
| Phathom Pharmaceuticals Inc | 350.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.22M |
| Total Expenses (Quarterly) | 9.066M |
| EPS Diluted (Quarterly) | -0.18 |
| Earnings Yield | -82.01% |